Skip to Main Content

Author Details

Jeannig Berrou
Universite Paris Cite, Institut de Recherche Saint-Louis
1995
24
14
Antoine Forget (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36431240Preclinical Evaluation of a Novel Small Molecule Inhibitor of LIM Kinases (LIMK) CEL_Amide in Philadelphia-Chromosome Positive (<i>BCR::ABL+</i>) Acute Lymphoblastic Leukemia (ALL).J Clin Med2022
35474100Cystine uptake inhibition potentiates front-line therapies in acute myeloid leukemia.Leukemia2022
35750691A multiparametric niche-like drug screening platform in acute myeloid leukemia.Blood Cancer J2022
33373830Synergy of FLT3 inhibitors and the small molecule inhibitor of LIM kinase1/2 CEL_Amide in FLT3-ITD mutated Acute Myeloblastic Leukemia (AML) cells.Leuk Res2021
31751766BET inhibitors impair leukemic stem cell function only in defined oncogenic subgroups of acute myeloid leukaemias.Leuk Res2019
25989842BET inhibitor OTX015 targets BRD2 and BRD4 and decreases c-MYC in acute leukemia cells.Oncotarget2015
26798861Natural Killer Lymphocytes Are Dysfunctional in Kidney Transplant Recipients on Diagnosis of Cancer.Transplantation2015
23676830Natural killer cell dysfunction in uremia: the role of oxidative stress and the effects of dialysis.Blood Purif2013
23638076Natural killer cell function, an important target for infection and tumor protection, is impaired in type 2 diabetes.PLoS One2013
18754036NKG2D ligands expression and NKG2D-mediated NK activity in Sezary patients.J Invest Dermatol2009
19155520Oxidative stress mediates a reduced expression of the activating receptor NKG2D in NK cells from end-stage renal disease patients.J Immunol2009
19288028Advanced glycation end products regulate extracellular matrix protein and protease expression by human glomerular mesangial cells.Int J Mol Med2009
19258596Acute graft-versus-host disease transiently impairs thymic output in young patients after allogeneic hematopoietic stem cell transplantation.Blood2009
12897066Type 1 plasminogen activator inhibitor deficiency aggravates the course of experimental glomerulonephritis through overactivation of transforming growth factor beta.FASEB J2003
11477146Role of thrombin receptors in the kidney: lessons from PAR1 knock-out mice.Nephrol Dial Transplant2001
11280040[Plasminogen activator inhibitor type 1: physiology and role in renal physiopathology].Nephrologie2001
11351280Internalisation of the protease-activated receptor 1: role of the third intracellular loop and of the cytoplasmic tail.Int J Mol Med2001
11701999Induction of urokinase receptor expression in nephrotoxic nephritis.Exp Nephrol2001
11602852Prognostic value of plasminogen activator inhibitor type 1 mRNA in microdissected glomeruli from transplanted kidneys.Transplantation2001
11494060Role of the third intracellular loop and of the cytoplasmic tail in the mitogenic signaling of the protease-activated receptor 1.Int J Mol Med2001
9551399Subtractive hybridization cloning: an efficient technique to detect overexpressed mRNAs in diabetic nephropathy.Kidney Int1998
9568850Tissue-type plasminogen activator activity in HIV-associated HUS.Nephrol Dial Transplant1998
8943472Specific receptor binding of renin on human mesangial cells in culture increases plasminogen activator inhibitor-1 antigen.Kidney Int1996
7503720Endothelin-1 induces rapid and long lasting internalization of the thrombin receptor in human glomerular epithelial cells.Biochem Biophys Res Commun1995
  • 1 - 24 of 24

Recommended Authors

Shanghai General Hospital, Shanghai Jiaotong University
Career Start Year 2007
Number of shared co-authors 1
Toronto General Research Institute, University Health Network
Career Start Year 2007
Number of shared co-authors 0
University of Amsterdam
Career Start Year 2003
Number of shared co-authors 0
Interfaculty Institute for Cell Biology.
Career Start Year 2003
Number of shared co-authors 0
The Ohio State University Wexner Medical Center
Career Start Year 2002
Number of shared co-authors 0
Centre Hospitalier Universitaire de Nantes, Nantes Universite, Inserm
Career Start Year 2001
Number of shared co-authors 0
Schulich School of Medicine and Dentistry, The University of Western Ontario
Career Start Year 2000
Number of shared co-authors 0
Knight Cancer Institute, Oregon Health & Science University
Career Start Year 1998
Number of shared co-authors 0
University of Eastern Piedmont.
Career Start Year 1998
Number of shared co-authors 0
University Medical Center Hamburg-Eppendorf
Career Start Year 1998
Number of shared co-authors 1
University of Louisville School of Medicine
Career Start Year 1998
Number of shared co-authors 1
Medical University Innsbruck
Career Start Year 1997
Number of shared co-authors 0
Medical Clinic and Policlinic IV, University of Munich
Career Start Year 1996
Number of shared co-authors 1
University of Toronto
Career Start Year 1996
Number of shared co-authors 1
Ulm University
Career Start Year 1995
Number of shared co-authors 1
University Hospital of the Ludwig Maximilians University Munich
Career Start Year 1995
Number of shared co-authors 0
The University of Cincinnati
Career Start Year 1994
Number of shared co-authors 0
University of Michigan ann arbor
Career Start Year 1992
Number of shared co-authors 1
Universite de Montreal
Career Start Year 1991
Number of shared co-authors 0
University of California Los Angeles
Career Start Year 1986
Number of shared co-authors 0
National Institutes of Health, National Institute of Diabetes
Career Start Year 1983
Number of shared co-authors 1
Universite Cote d'Azur, INSERM U5
Career Start Year 1982
Number of shared co-authors 14
Division of Nephrology and Center for Immunity, University of Virginia
Career Start Year 1982
Number of shared co-authors 0
University of Nebraska Medical Center
Career Start Year 1980
Number of shared co-authors 0
Child and Family Research Institute, University of British Columbia
Career Start Year 1979
Number of shared co-authors 0
Cambridge University Hospitals NHS Foundation
Career Start Year 1979
Number of shared co-authors 0
University of California san francisco
Career Start Year 1978
Number of shared co-authors 0
National Cancer Institute
Career Start Year 1976
Number of shared co-authors 0
Icahn School of Medicine at Mount Sinai
Career Start Year 1976
Number of shared co-authors 1
Brigham & Women's Hospital
Career Start Year 1975
Number of shared co-authors 0

Collaborators

Centre Hospitalier Universitaire Hopital Avicenne
Co-authored papers 6
Institut de Recherche Saint-Louis, Universite de Paris
Co-authored papers 6
Avicenne Hospital
Co-authored papers 5
Saint-Louis Hospital
Co-authored papers 4
Universite Paris Diderot
Co-authored papers 4
Universite Paris Cite, INSERM, CNRS
Co-authored papers 4
Assistance Publique des Hopitaux de Paris (AP-HP)
Co-authored papers 3
Universite de Strasbourg
Co-authored papers 3
Universite de Paris, INSERM, CNRS
Co-authored papers 3
Universite Paris Cite, INSERM, CNRS
Co-authored papers 2
Assistance Publique-Hopitaux de Paris, Universite de Paris
Co-authored papers 2
Universite Paris Cite, INSERM, CNRS
Co-authored papers 2
Universite Paris Cite, INSERM, CNRS
Co-authored papers 2
Universite Paris Cite, INSERM, CNRS
Co-authored papers 2
Universite Paris Cite, INSERM, CNRS
Co-authored papers 2
Universite Paris Cite, INSERM, CNRS
Co-authored papers 1
University of California San Francisco
Co-authored papers 1
Universite Paris Cite, INSERM, CNRS
Co-authored papers 1
Dana-Farber Cancer Institute
Co-authored papers 1
Universite Paris Cite, INSERM, CNRS
Co-authored papers 1
Chaoyang University of Technology
Co-authored papers 1
Universite Paris Cite, INSERM, CNRS
Co-authored papers 1
University of Cambridge
Co-authored papers 1
INSERM U1170, Universite Paris Saclay
Co-authored papers 1
Universite Paris Cite, INSERM, CNRS
Co-authored papers 1
University of Michigan ann arbor
Co-authored papers 1
Universite Paris Cite, INSERM, CNRS
Co-authored papers 1
Universite Paris Cite, INSERM, CNRS
Co-authored papers 1
Dana-Farber Cancer Institute
Co-authored papers 1
Universite Paris-Saclay
Co-authored papers 1